UK markets closed
NIKKEI 225
38,570.76 +88.65 (+0.23%) HANG SENG
18,430.39 +514.84 (+2.87%) CRUDE OIL
81.47 -0.10 (-0.12%) GOLD FUTURES
2,342.70 -4.20 (-0.18%) DOW
38,834.86 +56.76 (+0.15%) Bitcoin GBP
50,987.37 +241.59 (+0.48%)
ARQT Dec 2024 7.500 put
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 10:37AM EDT. Market open.
| Previous close | 1.9900 |
| Open | 1.6000 |
| Bid | 1.4000 |
| Ask | 2.7000 |
| Strike | 7.50 |
| Expiry date | 2024-12-20 |
| Day's range | 1.6000 - 1.6000 |
| Contract range | N/A |
| Volume | |
| Open interest | 61 |
ZacksOVID Slumps 76% on Epilepsy Drug Failing Two Pivotal Studies
Two late-stage studies, which evaluated Ovid Therapeutics' (OVID) experimental drug for two forms of epilepsy, fail to meet their primary endpoints.
ZacksHas Arcutis Biotherapeutics (ARQT) Outpaced Other Medical Stocks This Year?
Here is how Arcutis Biotherapeutics, Inc. (ARQT) and Boston Scientific (BSX) have performed compared to their sector so far this year.
ZacksWall Street Analysts Think Arcutis Biotherapeutics (ARQT) Could Surge 99.89%: Read This Before Placing a Bet
The average of price targets set by Wall Street analysts indicates a potential upside of 99.9% in Arcutis Biotherapeutics (ARQT). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
© 2024 Yahoo. All rights reserved.